isospaglumic acid has been researched along with beta-endorphin in 1 studies
| Studies (isospaglumic acid) | Trials (isospaglumic acid) | Recent Studies (post-2010) (isospaglumic acid) | Studies (beta-endorphin) | Trials (beta-endorphin) | Recent Studies (post-2010) (beta-endorphin) |
|---|---|---|---|---|---|
| 469 | 31 | 116 | 6,480 | 409 | 444 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, AR; Weatherspoon, JK; Werling, LL | 1 |
1 other study(ies) available for isospaglumic acid and beta-endorphin
| Article | Year |
|---|---|
Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen.
Topics: Animals; Antipsychotic Agents; beta-Endorphin; Caudate Nucleus; Dipeptides; Domperidone; Dopamine; Drug Design; Guinea Pigs; Humans; Male; N-Methylaspartate; Neurotensin; Nomifensine; Nucleus Accumbens; Prefrontal Cortex; Putamen; Schizophrenic Psychology; Secretory Rate | 1996 |